- Home
- PERF vs STXS Comparison
PERF vs STXS Comparison
Compare PERF & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PERF
- STXS
- Stock Information
- Founded
- PERF 2015
- STXS 1990
- Country
- PERF Taiwan
- STXS United States
- Employees
- PERF N/A
- STXS N/A
- Industry
- PERF Computer Software: Prepackaged Software
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PERF Technology
- STXS Health Care
- Exchange
- PERF Nasdaq
- STXS Nasdaq
- Market Cap
- PERF 197.6M
- STXS 173.5M
- IPO Year
- PERF N/A
- STXS 2004
- Fundamental
- Price
- PERF $1.85
- STXS $2.05
- Analyst Decision
- PERF Buy
- STXS Strong Buy
- Analyst Count
- PERF 2
- STXS 2
- Target Price
- PERF $4.00
- STXS $4.50
- AVG Volume (30 Days)
- PERF 59.2K
- STXS 368.0K
- Earning Date
- PERF 10-29-2024
- STXS 11-11-2024
- Dividend Yield
- PERF N/A
- STXS N/A
- EPS Growth
- PERF N/A
- STXS N/A
- EPS
- PERF 0.05
- STXS N/A
- Revenue
- PERF $58,445,000.00
- STXS $25,143,000.00
- Revenue This Year
- PERF $15.77
- STXS $1.16
- Revenue Next Year
- PERF $13.89
- STXS $55.65
- P/E Ratio
- PERF $36.84
- STXS N/A
- Revenue Growth
- PERF 15.84
- STXS N/A
- 52 Week Low
- PERF $1.70
- STXS $1.51
- 52 Week High
- PERF $3.77
- STXS $3.29
- Technical
- Relative Strength Index (RSI)
- PERF 46.80
- STXS 53.12
- Support Level
- PERF $1.78
- STXS $1.96
- Resistance Level
- PERF $1.92
- STXS $2.11
- Average True Range (ATR)
- PERF 0.08
- STXS 0.13
- MACD
- PERF 0.00
- STXS 0.01
- Stochastic Oscillator
- PERF 45.63
- STXS 50.00
About PERF Perfect Corp.
Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions that are ultra-personalized, interactive and engaging, from online to in-store through beauty mirrors. Geographically, the company has a presence in the United States, France, Japan and Others.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.